828. Promoter Strength Versus Transactivation Potential: Creating a Safer Integrating Vector

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Creating Safer Drinking Environments

The focus of the chapter is violence and crime in the licensed drinking environment. The central argument is that creating safer licensed environments is primarily a regulatory problem, not just an “alcohol problem”, and that formal enforcement is a necessary but not sufficient tool for creating a culture of compliance. A system of regulation that is responsive to industry conditions will rely ...

متن کامل

Nondividing cells: a safer bet for integrating vectors?

efficient in penetrating tumor tissues as compared with antibodies, and the results confirm that only three injections of T cells are necessary for complete tumor regression. However, only a comparative study using antibodies and engineered T cells will validate this claim. Patients treated with CAR-engineered T cells could also develop resistance similar to that in lymphoma patients in whom CD...

متن کامل

6s: Creating an Efficient and Safer Work Environment

Purpose: This paper explores the concept of workplace organisation and the role of safety. Specifically the objectives of the study were to identify the role of safety within 5S and to test how the extension of the method (to 6S) can explicitly and effectively integrate safety with productivity and quality. Design/methodology/approach: An action research approach was employed which enabled the ...

متن کامل

A David promoter with Goliath strength.

In this issue of Blood, Nair et al report on a computationally derived hepatocyte-specific cis-regulatory module (HS-CRM8) to accomplish high tissue-specific expression in gene therapy for hemophilia. When HS-CRM8 is introduced upstream of a minimal liver-specific promoter in an adenoassociated virus (AAV) that expresses a codon-optimized hyperactive human factor IX (FIX) mutant (FIX Padua), it...

متن کامل

NpgRJ_NN_1910 828..837

We identified a mutation in Aats-gly (also known as gars or glycyl-tRNA synthetase), the Drosophila melanogaster ortholog of the human GARS gene that is associated with Charcot-Marie-Tooth neuropathy type 2D (CMT2D), from a mosaic genetic screen. Loss of gars in Drosophila neurons preferentially affects the elaboration and stability of terminal arborization of axons and dendrites. The human and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Molecular Therapy

سال: 2006

ISSN: 1525-0016

DOI: 10.1016/j.ymthe.2006.08.913